← Back to Search

Stents for Glaucoma

N/A
Waitlist Available
Research Sponsored by Glaukos Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Open angle Glaucoma
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights

Study Summary

This trial is testing two different treatments for open angle glaucoma - Trabecular Micro-Bypass stents and laser trabeculoplasty. The safety and effectiveness of both treatments will be evaluated.

Eligible Conditions
  • Glaucoma

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
IOP reduction
Secondary outcome measures
% IOP reduction

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SurgicalExperimental Treatment1 Intervention
Implantation of two Trabecular Meshwork stents into the study eye
Group II: LaserActive Control2 Interventions
Laser Trabeculoplasty

Find a Location

Who is running the clinical trial?

Glaukos CorporationLead Sponsor
65 Previous Clinical Trials
8,949 Total Patients Enrolled
36 Trials studying Glaucoma
4,974 Patients Enrolled for Glaucoma
Kerry Stephens, ODStudy ChairGlaukos Corporation
4 Previous Clinical Trials
774 Total Patients Enrolled
2 Trials studying Glaucoma
13 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new volunteers being accepted for this clinical experiment currently?

"Clinicaltrials.gov records indicate that this trial is not presently taking on new patients, with the initial post dating back to November 1st 2014 and last updated April 29th 2021. However, there are 88 other studies actively recruiting candidates at present."

Answered by AI

Where can patients access this clinical trial?

"At the moment, this trial is enrolling participants from 9 different locations including Fayetteville, San Antonio and Memphis. To reduce potential travel burdens for patients, it may be wise to select a nearby centre."

Answered by AI
~9 spots leftby Mar 2025